News 2024-12-19
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian
Porton Successfully Hosts Ceremony for New Modality Capacity UpgradeDrug Modalities: Innovative Services & Solutions from Porton Pharma
Click to Download
Others
More
News 2025-02-13
Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts
Porton Pharma Solutions is thrilled to announce its participation in several major industry events across the globe during the first and second quarters of 2025. As a leading end-to-end integrated CDMO company, Porton boasts globally advanced technology platforms and extensive project delivery experience in small molecules, peptides and oligonucleotides, ADCs (including antibodies, payload-linkers, conjugation, and drug product filling), and Advanced Therapy Medicinal Products.
News 2025-01-28
Our Incredible Journey in 2024
Under open skies, the years pass endlessly. As the sun rises, Porton welcomes a new year with sincerity and hope. Reflecting on 2024, we faced challenges together, standing strong and united, achieving great heights.
